COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register

Middleton, R. M.; Craig, E. M.; Rodgers, W. J.; Tuite-Dalton, K.; Garjani, A.; Evangelou, N.; das Nair, R.; Hunter, R.; Tallantyre, E. C.; Cauchi, M.; Cairn, C.; Paling, D.; Fuller, S.; McDonnell, G.; Petherham, K.; Liu, B.; Nock, U.; Ingram, G.; Brownlee, W.; Taylor, J.; Nicholas, R.; UK Multiple Sclerosis Register Research Group

doi:10.1016/j.msard.2021.103317

All Outputs (1)

COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register (2021)
Journal Article
Middleton, R. M., Craig, E. M., Rodgers, W. J., Tuite-Dalton, K., Garjani, A., Evangelou, N., …UK Multiple Sclerosis Register Research Group. (2021). COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register. Multiple Sclerosis and Related Disorders, 56, Article 103317. https://doi.org/10.1016/j.msard.2021.103317

Background: In March 2020, the United Kingdom Multiple Sclerosis Register (UKMSR) established an electronic case return form, designed collaboratively by MS neurologists, to record data about COVID-19 infections in people with MS (pwMS). Objectives:... Read More about COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register.